BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16102934)

  • 1. Sulfiredoxin: a potential therapeutic agent?
    Findlay VJ; Tapiero H; Townsend DM
    Biomed Pharmacother; 2005 Aug; 59(7):374-9. PubMed ID: 16102934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
    Park JW; Mieyal JJ; Rhee SG; Chock PB
    J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
    Mishra M; Jiang H; Wu L; Chawsheen HA; Wei Q
    Cancer Lett; 2015 Oct; 366(2):150-9. PubMed ID: 26170166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
    Rhee SG; Jeong W; Chang TS; Woo HA
    Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for human sulfiredoxin in the reversal of glutathionylation.
    Findlay VJ; Townsend DM; Morris TE; Fraser JP; He L; Tew KD
    Cancer Res; 2006 Jul; 66(13):6800-6. PubMed ID: 16818657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
    Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
    J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
    Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
    J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
    Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
    J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression.
    Jeong W; Bae SH; Toledano MB; Rhee SG
    Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
    Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
    J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.
    Jeong W; Park SJ; Chang TS; Lee DY; Rhee SG
    J Biol Chem; 2006 May; 281(20):14400-7. PubMed ID: 16565085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.
    Lowther WT; Haynes AC
    Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
    Jönsson TJ; Murray MS; Johnson LC; Lowther WT
    J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
    Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG
    Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arabidopsis thaliana sulfiredoxin is a plastidic cysteine-sulfinic acid reductase involved in the photooxidative stress response.
    Rey P; Bécuwe N; Barrault MB; Rumeau D; Havaux M; Biteau B; Toledano MB
    Plant J; 2007 Feb; 49(3):505-14. PubMed ID: 17217469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia.
    Bae SH; Woo HA; Sung SH; Lee HE; Lee SK; Kil IS; Rhee SG
    Antioxid Redox Signal; 2009 May; 11(5):937-48. PubMed ID: 19086807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response.
    Lei K; Townsend DM; Tew KD
    Oncogene; 2008 Aug; 27(36):4877-87. PubMed ID: 18454177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators.
    Chae HZ; Oubrahim H; Park JW; Rhee SG; Chock PB
    Antioxid Redox Signal; 2012 Mar; 16(6):506-23. PubMed ID: 22114845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathionylation of Pea Chloroplast 2-Cys Prx and Mitochondrial Prx IIF Affects Their Structure and Peroxidase Activity and Sulfiredoxin Deglutathionylates Only the 2-Cys Prx.
    Calderón A; Lázaro-Payo A; Iglesias-Baena I; Camejo D; Lázaro JJ; Sevilla F; Jiménez A
    Front Plant Sci; 2017; 8():118. PubMed ID: 28197170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
    Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
    Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.